0001209191-13-048483.txt : 20131016
0001209191-13-048483.hdr.sgml : 20131016
20131016162135
ACCESSION NUMBER: 0001209191-13-048483
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131014
FILED AS OF DATE: 20131016
DATE AS OF CHANGE: 20131016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6173416100
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 131154426
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-10-14
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
0
1
0
0
SVP & Corp Controller
Common Stock
2013-10-14
4
M
0
468
33.82
A
12218
D
Common Stock
2013-10-14
4
M
0
1125
51.75
A
13343
D
Common Stock
2013-10-14
4
S
0
214
70.41
D
13129
D
Common Stock
2013-10-14
4
S
0
500
71.57
D
12629
D
Common Stock
2013-10-14
4
S
0
754
72.26
D
11875
D
Common Stock
2013-10-14
4
S
0
125
73.22
D
11750
D
Common Stock
169
I
401(k)
Stock Option (right to buy)
33.82
2013-10-14
4
M
0
468
0.00
D
2020-07-13
Common Stock
468
1407
D
Stock Option (right to buy)
51.75
2013-10-14
4
M
0
1125
0.00
D
2021-07-12
Common Stock
1125
7875
D
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $70.41 (range $70.00 to $70.85).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $71.57 (range $71.00 to $71.93).
Open market sales reported on this line occurred at a weighted average price of $72.26 (range $72.01 to $72.89).
The option vests in 16 quarterly installments from 07/14/2010.
The option vests in 16 quarterly installments from 07/13/2011.
Kenneth L. Horton, Attorney-In-Fact
2013-10-16